Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2019 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2019 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Dynamic Nestin expression during hair follicle maturation and the normal hair cycle

  • Authors:
    • Ruosi Chen
    • Yong Miao
    • Zhiqi Hu
  • View Affiliations / Copyright

    Affiliations: Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Guangzhou, Guangdong 510515, P.R. China
  • Pages: 549-554
    |
    Published online on: November 26, 2018
       https://doi.org/10.3892/mmr.2018.9691
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Nestin, a type-VI intermediate filament protein, serves as a marker for neural stem cells, and is also known to be expressed in follicle stem cells. Hair follicles go through repeated cycles of anagen (growth), catagen (regression) and telogen (quiescence) throughout the life of mammals following morphogenesis. In the present study it was demonstrated that in mice, the maturation of hair follicles includes the period between morphogenesis and the first anagen (4 weeks of age). Skin samples from Nestin‑green fluorescent protein (GFP)+ mice at different hair follicle stages were collected, and immunostaining for Nestin and Ki67 was performed. It was identified that during morphogenesis, Nestin‑GFP expression was rarely detected and it gradually increased during maturation (0‑4 weeks) in hair follicle dermal cells. In mature hair follicle dermal cells, Nestin and the proliferation marker Ki67 were highly expressed in anagen, while during telogen, they were markedly decreased. Additionally, lineage tracing data demonstrated that peri‑follicular Nestin+ cells during morphogenesis differentiated into cluster of differentiation 31+ cells.

Introduction

As the primary barrier to the body, the skin protects against dehydration, mechanical injury and microbial infection (1). Skin is composed of an outer epidermis and the underlying dermis separated by a basement membrane. Hair follicles are highly sensitive mini-organs comprising epidermal keratinocytes and mesenchymal compartments (2–4). Hair growth is a cyclic regeneration phenomenon regulated by connections between epithelial and dermal compartments (5–8). Hair follicles go through repeated cycles of anagen (growth), catagen (regression) and telogen (quiescence) throughout the life of mammals (9–12). Prior to the start of each cycle there is a phase of hair follicle morphogenesis. Hair follicle morphogenesis and the subsequent hair phases follow a precise timescale (13). The period beginning with hair morphogenesis until the first hair cycle is considered to be the maturation of the hair follicle.

Nestin, originally discovered in neuroepithelial stem cells, is an intermediate filament protein expressed during the early stages of development (1,14). Hair follicles contain a distinct population of follicular stem cells that express Nestin (15). Using Nestin-green fluorescent protein (GFP) transgenic mice, researchers demonstrated that during telogen and in early anagen, Nestin-GFP+ cells are primarily in the bulge area (9,16). However, in mid- and late anagen, the GFP-expressing cells are located in the upper outer-root sheath in addition to the bulge area (9). However, Nestin expression between morphogenesis and the postnatal regular hair cycle is not well studied. In the present study, it was demonstrated that during morphogenesis, Nestin-GFP expression was detected rarely, and gradually increased during maturation (0–4 weeks) in hair follicle dermal cells. In mature hair follicle dermal cells, Nestin and Ki67 were highly expressed in anagen, while during telogen, they were markedly decreased. Additionally, the lineage tracing data demonstrated that peri-follicular Nestin+ cells during morphogenesis differentiated into vascular cells.

Materials and methods

Animals and treatment

Nestin-GFP mice were provided by Dr Grigori Enikolopov at Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, USA). Nestin-CreERT2mice (stock no. 003771) and B6.129X1-Gt (ROSA) 26Sortm1 [enhanced yellow fluorescent protein (EYFP)] Cos/J mice (stock no. 006148) were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Five male mice were used in each group. The mice were 8-days-old, 2-weeks-old, 4-weeks-old, 8-weeks-old and 12-weeks-old, whose average weight were 5, 7, 12, 19 and 25 g, respectively. For the lineage tracing experiment, mice were injected with tamoxifen (80 mg/kg) to induce Cre-ER activity 8 days (P8) following birth and tested at 4 weeks old. All animal experiments were performed under the approval of the Institutional Animal Care and Use Committee at Southern Medical University (Guangzhou, China). Mice were housed at the Department of Laboratory Animal Science, Southern Medical University (Guangzhou, China), and maintained under a 12-h light/dark cycle, an ambient temperature of 22±2°C and a constant humility of 60±10%, with food and water provided ad libitum.

Flow cytometry analysis

For flow cytometry analysis of Nestin-GFP− and GFP+ cells from the whole skin, the skin from Nestin-GFP mice was dissected. Following hair removal, the skin was lightly defatted before 2 ml of Trypsin-EDTA (0.5%, 10X; Thermo Fisher Scientific, Inc., Waltham, MA, USA) was added, followed by incubation at 4°C overnight. Dermis were separated and cut into small pieces, followed by digestion in protease solution [2 mg/ml collagenase I and 2.5 mg/ml trypsin in phosphate-buffered saline (PBS) at 37°C] for 1 h. Cells within the supernatant were collected for flow cytometry. Following red blood cell lysis (in order to remove the hemocytes) with commercial ammonium chloride-potassium lysis buffer (Quality Biological, Inc., Gaithersburg, MD, USA), the cells were analyzed according to CD45 and GFP expression. Flow cytometry analysis was performed using a FACSCalibur flow cytometer and CellQuest software (version 5.1, Becton-Dickinson Biosciences). The primary antibodies used were FITC-conjugated anti-mouse GFP (cat. no. 338008; 1:200; BioLegend, Inc., San Diego, CA, USA), PerCP-conjugated anti-mouse CD45 (cat. no. 103130; 1:200; BioLegend, Inc.). Briefly, dermal cells were blocked with 1% BSA (cat. no. 05470; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for 30 min on ice and following washing with PBS, the primary antibodies were added and incubated on ice for 15 min.

Immunofluorescence

Following sacrifice, the skin of the mice was resected and fixed in 4% ice-cold paraformaldehyde solution for 1 h and decalcified by immersion in 30% sucrose for 24 h. Finally, tissues were embedded in optimal cutting temperature compound (Sakura Finetek USA, Inc, Torrance, CA, USA). Sections of skin (10-µm thick) were harvested for immunofluorescence staining.

For the staining, the sections were incubated with the following primary antibodies: Mouse Ki67 (cat. no. ab15580; 1:200), GFP (cat. no. ab290; 1:200) and cluster of differentiation (CD)31 (cat. no. ab28364; 1:50) (all from Abcam, Cambridge, UK). Slides were rinsed with TBST (cat. no. T5912; Sigma-Aldrich; Merck KGaA), blocked with 3% BSA (cat. no. 05470; Sigma-Aldrich; Merck KGaA) for 1 h at room temperature and then incubated with the primary antibody overnight at 4°C, followed by incubation with FITC or Cy3-conjugated secondary antibodies (FITC-conjugated secondary antibodies: cat. no. 711–546-152; 1:1,000; Cy3-conjugated secondary antibodies: cat. no. 711-167-003; 1:1,000; Jackson ImmunoResearch Europe, Ltd., Newmarket UK) for 1 h at room temperature in the dark. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (Sigma-Aldrich; Merck KGaA). The sections were mounted with the ProLong Antifade kit (Molecular Probes; Thermo Fisher Scientific, Inc.) and were observed under a Zeiss LSM780 confocal microscope (Zeiss AG, Oberkochen, Germany).

Statistical analysis

Data are presented as the mean ± standard deviation of 3 independent experiments. One-way analysis of variance followed by the Bonferroni post hoc test was applied. All data were normally distributed and had similar variation between groups. Statistical analysis was performed using SAS version 9.3 software (SAS Institute, Inc., Cary, NC, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

Maturation of hair follicle dermal cells is characterized by gain-of-nestin expression

Nestin is required for the self-renewal, proliferation and cell cycle progression of hair follicle cells (17–19). The mouse hair cycle follows a precise time scale. A gradual induction of Nestin-GFP signaling was detected in male Nestin-GFP+ mice in hair follicle dermal cells at P8, and in 2- and 4-week-old mice (Fig. 1A and B). According to the immunofluorescence staining results, Nestin-GFP was expressed at low levels at P8 (morphogenesis) in hair follicle dermal cells and progressively increased at 2 and 4 weeks of age (first catagen and anagen; Fig. 1A and B). Therefore, it appeared that the period spanning morphogenesis until the first anagen represented the maturation of hair follicle and, following this, hair follicles follow a regular hair cycle.

Figure 1.

HF dermal cells in the dermis layer exhibit Nestin expression during hair morphogenesis. Representative images of (A) immunofluorescence staining and (B) quantitative analysis of GFP+ cells, (C) immunofluorescence staining and (D) quantification of Ki67+ cells, and (E) immunofluorescence staining and (F) quantification of GFP+/Ki67+cells, in the dermis layer from P8, 2- and 4-week-old male Nestin-GFP+ mice (n=5). GFP is in green, Ki67 in red and DAPI stains the nuclei blue. GFP, green fluorescent protein; DAPI, 4′,6-diamidino-2-phenylindole; HF, hair follicle. *P<0.05.

Mature hair follicle dermal cells co-express nestin and Ki67 during anagen

Given the induction of Nestin-GFP signaling in male Nestin-GFP mice during maturation, the proliferation capacity of hair follicle dermal cells during this period was investigated by immunofluorescence staining with the Ki67 proliferation marker. The high amount of Ki67+ dermal cells observed at P8 (morphogenesis) indicated that the cells have high proliferative activity during morphogenesis. Ki67 expression was substantially maintained at 2 weeks of age, when the first catagen begins, and increased at 4 weeks, when first anagen begins (Fig. 1C and D). Notably, co-immunofluorescence staining of Ki67 and Nestin-GFP at different time points indicated that at P8, few Ki67+ hair follicle dermal cells also expressed Nestin-GFP. At 2 weeks, nearly 20% of Ki67+ hair follicle dermal cells expressed Nestin-GFP (Fig. 1E and F). In 4-week-old mice, nearly all Ki67+ hair follicle dermal cells expressed Nestin-GFP, indicating that mature Nestin+ hair follicle dermal cells are of high proliferative capacity during the first anagen (Fig. 1E and F). During the maturation of hair follicles, hair follicle dermal cells begin expressing Nestin, and mature cells are of high proliferative capacity.

Dynamic nestin expression during the normal hair cycle in hair follicle dermal cells

Whether Nestin is highly expressed during the normal hair cycle was also investigated. To determine this, skin from 4-, 8- and 12-week-old male Nestin-GFP+ mice was collected, corresponding to the first anagen, second telogen and second anagen of the murine hair cycle, respectively. Nestin-GFP was highly expressed in anagen (growing phase; 4 and 12 weeks) and significantly decreased in telogen (quiescent phase; 8 weeks; Fig. 2A and B).

Figure 2.

Dynamic Nestin expression in HF dermal cells during the hair cycle. Representative images of (A) immunofluorescence staining and (B) quantitative analysis of GFP+ cells, (C) immunofluorescence staining and (D) quantification of Ki67+ cells, and (E) immunofluorescence staining and (F) quantification of GFP+/Ki67+cells, in the dermis layer from 4-, 8- and 12-week-old male Nestin-GFP+ mice (n=5). GFP is in green, Ki67 in red and DAPI stains the nuclei blue. GFP, green fluorescent protein; DAPI, 4′,6-diamidino-2-phenylindole; HF, hair follicle. *P<0.05.

Nestin may serve as marker of high proliferation during the normal hair cycle

To investigate Ki67 expression during the normal hair cycle in hair follicle dermal cells, Ki67 immunofluorescence staining was performed on 4-, 8- and 12-week-old male Nestin-GFP+ mice. High Ki67 expression levels were observed at 4 and 12 weeks, representing the first and second anagen of the murine hair cycle, respectively, indicating that the cells were in a highly proliferative state. At 8 weeks, when mouse hair follicles were in telogen (quiescent phase), Ki67 expression levels were significantly decreased (Fig. 2C and D). Co-immunofluorescence staining of Ki67 and Nestin-GFP indicated that nearly all Ki67+ cells were also Nestin-GFP+, and the expression of the two markers was increased in anagen and decreased in telogen (Fig. 2E and F). The fact that Nestin had the same expression pattern as Ki67 during the normal hair cycle in hair follicle dermal cells indicated that Nestin may serve as a marker of high proliferation during the normal hair cycle. Furthermore, flow cytometry analysis of the isolated cells demonstrated that the percentage of GFP+ cells was gradually increased in mice of 2 and 4 weeks of age compared with those at 8 days of age, which was in accordance with the immunofluorescence staining results (Fig. 3A and B). Additionally, flow cytometry analysis of the isolated cells demonstrated that the percentage of GFP+ cells was increased during anagen (12 weeks) and decreased during telogen (8 weeks; Fig. 3C and D).

Figure 3.

Flow cytometry analysis of dynamic Nestin expression in hair follicle dermal cells. Representative images of (A) flow cytometry analysis and (B) quantification of the GFP+ cells in the skin of P8, 2- and 4-week-old mice, followed by (C) flow cytometry analysis and (D) quantification of the GFP+ cells, in the skin of 4-, 8- and 12-week-old male Nestin-GFP mice. GFP, green fluorescent protein; FITC, fluorescein isothiocyanate. *P<0.05.

Nestin positive cells also express CD31

At P8, when morphogenesis occurs, Nestin-GFP was rarely expressed in hair follicle dermal cells. However, Nestin-GFP+ cells were detected in the peri-follicular area (Fig. 1A). The lineage fate of the Nestin+ cells was traced at P8 using Nestin-Cre::ROSA26-EYFP mice. Examination of the fate of Nestin-EYFP+ cells 3 weeks post-tamoxifen injection revealed that ~20% of the EYFP-labeled cells were also CD31+ (Fig. 4).

Figure 4.

Nestin+ cells are involved in dermis layer CD31+ vessel formation during hair morphogenesis. Nestin-Cre::ROSA26-EYFP mice were given a single dose of tamoxifen at P8. Representative images of (A) immunofluorescence staining and (B) quantitative analysis of CD31+/EYFP+ cells in skin dermis layer sections from 4-week-old male Nestin-Cre::ROSA26-EYFP mice (n=5). EYFP is presented in green, CD31 is red and DAPI stains the nuclei blue. DAPI, 4′,6-diamidino-2-phenylindole; EYFP, enhanced yellow fluorescent protein; CD31, cluster of differentiation 31.

Discussion

In mice, the first two postnatal hair cycles are synchronized (13). Hair follicles are an ideal system for studying how stem cells interact with progeny in the niche between quiescence and regeneration (5). Murine hair follicles undergo a precise hair cycle, which follows a specific timescale following hair morphogenesis (13). From birth to 2 weeks of age, murine hair follicles are in a morphogenic phase, followed by 2-, 3- and 4-weeks of age when hair follicles undergo the first postnatal catagen, telogen and anagen, respectively. The second hair cycle occurs at 6-, 7- and 12-weeks of age, indicating the second catagen, telogen and anagen, respectively (13). Using this guide to classify hair phases, a previous study demonstrated that Nestin is expressed in different hair follicle locations in different developmental phases (9). However, Nestin expression between morphogenesis and the postnatal regular hair cycle is not well studied.

Nestin, a type-VI intermediate filament protein, serves as a marker for neural stem cells and is also known to be expressed in follicle stem cells (14). Previous studies have demonstrated that Nestin is required for the self-renewal, proliferation and cell cycle progression of the cells, particularly in neural progenitor cells (17–19). Consistent with all these findings, the present study demonstrated that during the hair follicle cycle, there was a high percentage of Ki67+ cells among the Nestin-expressing cells in the dermis layer at 4 and 12 weeks following birth, which represent the first and second anagen of the murine hair cycle, respectively. Notably, at 8 weeks of age, which is the first telogen (quiescent phase), Ki67+/Nestin+ hair follicle cell numbers decreased. These results indicated the high proliferative capacity of these cells, likely due to a high demand for hair follicle replacement during anagen and not during telogen. All these results suggested that Nestin+ cells in the dermis layer proliferate more rapidly compared with Nestin− cells in the same region. A notable phenomenon from the present study is that during early hair follicle morphogenesis, Nestin-GFP+ cells gradually appeared in the dermis layer until the first anagen, which indicated that Nestin expression may be a sign of hair follicle maturation.

Previous findings revealed that Nestin-Cre+ and Nestin-GFP+ cells are able to label endothelial, mesenchymal lineage and Schwann precursor cells (20–24). At P8, when morphogenesis occurs, Nestin-GFP was rarely expressed in hair follicle dermal cells. However, Nestin-GFP+ cells were detected in the peri-follicular area. In the present study, a single dose of tamoxifen was administered to P8 Nestin-CreERT2; ROSA26-EYFP in order to preform lineage tracing, and skin samples were harvested after 3 weeks. It was illustrated that during hair follicle morphogenesis, peri-follicular Nestin+ cells also expressed CD31, which is an endothelial cell marker. This finding may divide Nestin+ cells in the dermis layer into two different populations: Peri-follicular Nestin+ cells during morphogenesis that are of endothelial lineage, and hair follicle Nestin+ cells that are hair follicle precursor cells.

In conclusion, the expression of Nestin in hair follicles during morphogenesis and maturation was investigated. Additionally, Nestin may serve as a marker of high proliferation during the normal hair cycle, and was highly expressed during anagen and decreased during telogen in the murine hair cycle. Furthermore, certain Nestin+ cells may serve a role in other processes, including angiogenesis during morphogenesis.

Acknowledgements

Not applicable.

Funding

The present study was supported by the Natural Science Foundation of China (grant nos. 81471900, 81701929 and 81772104) and the Natural Science Foundation of Guangdong Province (grant nos. 2015A030311001 and 2017A030310120) and the Science and Technology Planning Project of Guangzhou City (grant no. 201508020262).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

RC performed the experiments and wrote the manuscript. YM analyzed the data. ZH designed the study and critically revised the manuscript for important intellectual content.

Ethics approval and consent to participate

All animal experiments were performed under the approval of the Institutional Animal Care and Use Committee at Southern Medical University (Guangzhou, China).

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Falodah FA and Al-Karim S: Immuno- and gene expression analysis of EGFR and Nestin during mice skin development. Tissue Cell. 48:274–281. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Mistriotis P and Andreadis ST: Hair follicle: A novel source of multipotent stem cells for tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 19:265–278. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Takeo M, Lee W and Ito M: Wound healing and skin regeneration. Cold Spring Harb Perspect Med. 5:a0232672015. View Article : Google Scholar : PubMed/NCBI

4 

Myung PS, Takeo M, Ito M and Atit RP: Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration. J Invest Dermatol. 133:31–41. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Hsu YC, Li L and Fuchs E: Emerging interactions between skin stem cells and their niches. Nat Med. 20:847–856. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Higgins CA, Chen JC, Cerise JE, Jahoda CA and Christiano AM: Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair-follicle growth. Proc Natl Acad Sci USA. 110:19679–19688. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Biernaskie J, Paris M, Morozova O, Fagan BM, Marra M, Pevny L and Miller FD: SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell. 5:610–623. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Sennett R and Rendl M: Mesenchymal-epithelial interactions during hair follicle morphogenesis and cycling. Semin Cell Dev Biol. 23:917–927. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Li L, Mignone J, Yang M, Matic M, Penman S, Enikolopov G and Hoffman RM: Nestin expression in hair follicle sheath progenitor cells. ProcNatlAcad Sci USA. 100:9958–9961. 2003. View Article : Google Scholar

10 

Matsumura H, Mohri Y, Binh NT, Morinaga H, Fukuda M, Ito M, Kurata S, Hoeijmakers J and Nishimura EK: Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 35:1aad43952016.

11 

Kandyba E and Kobielak K: Wnt7b is an important intrinsic regulator of hair follicle stem cell homeostasis and hair follicle cycling. Stem Cells. 32:886–901. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Hoffman RM: Nestin-expressing hair follicle-accessible pluripotent stem cells for nerve and spinal cord repair. Cells Tissues Organs. 200:42–47. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Müller-Röver S, Handjiski B, van der Veen C, Eichmüller S, Foitzik K, McKay IA, Stenn KS and Paus R: A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 117:3–15. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Xie L, Zeng X, Hu J and Chen Q: Characterization of Nestin, a Selective marker for bone marrow derived mesenchymal stem cells. Stem Cells Int. 2015:7620982015. View Article : Google Scholar : PubMed/NCBI

15 

Amoh Y, Li L, Yang M, Moossa AR, Katsuoka K, Penman S and Hoffman RM: Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci USA. 101:13291–13295. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Uchugonova A, Cao W, Hoffman RM and Koenig K: Comparison of label-free and GFP multiphoton imaging of hair follicle-associated pluripotent (HAP) stem cells in mouse whiskers. Cell Cycle. 14:3430–3433. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Hu W, Lu H, Wang S, Yin W, Liu X, Dong L, Chiu R, Shen L, Lu WJ and Lan F: Suppression of Nestin reveals a critical role for p38-EGFR pathway in neural progenitor cell proliferation. Oncotarget. 7:87052–87063. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Park D, Xiang AP, Mao FF, Zhang L, Di CG, Liu XM, Shao Y, Ma BF, Lee JH, Ha KS, et al: Nestin is required for the proper self-renewal of neural stem cells. Stem Cells. 28:2162–2171. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Sahlgren CM, Mikhailov A, Vaittinen S, Pallari HM, Kalimo H, Pant HC and Eriksson JE: Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol. 23:5090–5106. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Isern J, Garcia-Garcia A, Martin AM, Arranz L, Martín-Pérez D, Torroja C, Sánchez-Cabo F and Méndez-Ferrer S: The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function. Elife. 3:e036962014. View Article : Google Scholar : PubMed/NCBI

21 

Kusumbe AP, Ramasamy SK, Itkin T, Mäe MA, Langen UH, Betsholtz C, Lapidot T and Adams RH: Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature. 532:380–384. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Ono N, Ono W, Mizoguchi T, Nagasawa T, Frenette PS and Kronenberg HM: Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage. Dev Cell. 29:330–339. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Itkin T, Gur-Cohen S, Spencer JA, Schajnovitz A, Ramasamy SK, Kusumbe AP, Ledergor G, Jung Y, Milo I, Poulos MG, et al: Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 532:323–328. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN and Frenette PS: Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 466:829–834. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen R, Miao Y and Hu Z: Dynamic Nestin expression during hair follicle maturation and the normal hair cycle. Mol Med Rep 19: 549-554, 2019.
APA
Chen, R., Miao, Y., & Hu, Z. (2019). Dynamic Nestin expression during hair follicle maturation and the normal hair cycle. Molecular Medicine Reports, 19, 549-554. https://doi.org/10.3892/mmr.2018.9691
MLA
Chen, R., Miao, Y., Hu, Z."Dynamic Nestin expression during hair follicle maturation and the normal hair cycle". Molecular Medicine Reports 19.1 (2019): 549-554.
Chicago
Chen, R., Miao, Y., Hu, Z."Dynamic Nestin expression during hair follicle maturation and the normal hair cycle". Molecular Medicine Reports 19, no. 1 (2019): 549-554. https://doi.org/10.3892/mmr.2018.9691
Copy and paste a formatted citation
x
Spandidos Publications style
Chen R, Miao Y and Hu Z: Dynamic Nestin expression during hair follicle maturation and the normal hair cycle. Mol Med Rep 19: 549-554, 2019.
APA
Chen, R., Miao, Y., & Hu, Z. (2019). Dynamic Nestin expression during hair follicle maturation and the normal hair cycle. Molecular Medicine Reports, 19, 549-554. https://doi.org/10.3892/mmr.2018.9691
MLA
Chen, R., Miao, Y., Hu, Z."Dynamic Nestin expression during hair follicle maturation and the normal hair cycle". Molecular Medicine Reports 19.1 (2019): 549-554.
Chicago
Chen, R., Miao, Y., Hu, Z."Dynamic Nestin expression during hair follicle maturation and the normal hair cycle". Molecular Medicine Reports 19, no. 1 (2019): 549-554. https://doi.org/10.3892/mmr.2018.9691
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team